Filter
1130
Filtered Results: 1130
Text search:
molecular
testing
Featured
Recommendations
156
New Publications
236
Language
Document type
No document type
548
Guidelines
242
Studies & Reports
183
Manuals
58
Strategic & Response Plan
48
Fact sheets
25
Training Material
12
Situation Updates
9
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
India
70
Western and Central Europe
41
Global
36
Latin America and the Carribbean
31
Africa
27
Eastern Europe
24
Kenya
23
South Africa
20
Tanzania
18
Ethiopia
17
Brazil
14
East and Southern Africa
13
West and Central Africa
13
Sierra Leone
11
Malawi
11
Russia
11
Uganda
10
Rwanda
10
Nigeria
9
Germany
9
Colombia
9
South–East Asia Region
9
Liberia
8
Philippines
8
Zambia
8
Asia
8
Nepal
7
Mozambique
7
Namibia
7
Peru
7
Zimbabwe
6
Indonesia
6
Bangladesh
6
Argentina
6
Senegal
5
Congo, Democratic Republic of
5
Ukraine
5
Myanmar / Burma
5
Middle East and North Africa
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
USA
4
Ghana
4
Pakistan
4
Syria
4
Angola
4
Guinea-Bissau
3
Cambodia
3
Eswatini/ Swaziland
3
Ecuador
3
Botswana
3
El Salvador
3
Chile
3
Vietnam
3
Spain
3
Guinea
2
Burkina Faso
2
Cameroon
2
South Sudan
2
Lebanon
2
Turkey
2
Bolivia
2
Venezuela
2
Tajikistan
2
Georgia
2
Haiti
1
Somalia
1
Jordan
1
Afghanistan
1
Gambia
1
Benin
1
Dominican Republic
1
North Macedonia
1
Cuba
1
Honduras
1
Guatemala
1
Lesotho
1
Mexico
1
Nicaragua
1
Palestine
1
Timor Leste/ East Timor
1
North America
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
335
Clinical Guidelines
169
Pharmacy & Technologies
52
Public Health
45
Key Resources
22
Women & Child Health
15
Capacity Building
4
Toolboxes
TB
255
COVID-19
160
AMR
81
HIV
75
NTDs
62
Rapid Response
59
Ebola
32
Mental Health
25
Planetary Health
23
Pharmacy
20
Zika
19
Refugee
14
Polio
12
NCDs
12
Specific Hazards
8
Caregiver
6
Cholera
5
Natural Hazards
4
Health Financing Toolbox
4
Disability
3
Conflict
3
Global Health Education
2
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
The brief concludes that sustaining the continuity of EHS requires policies that ensure a whole-society and systems strengthening approach. This involves increased health care investment, community engagement, disease control regulations, and multisector approaches to improve resilience, EHS quality...
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are needed in some cases to ensure full recovery.
The targ...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical expo...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
Epidemiological Update
Dengue
7 February 2020
Situation summary
In the Region of the Americas, between epidemiological week (EW) 1 and EW 521 of 2019, a total of 3,139,335 cases of dengue have been reported (321.58 cases per 100,000 population), including 1,538 deaths. Of the total cases, 1,367,...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
